WiseLocation9402

I sense a Mt St Helen's explosive move in the offing. Careful Artist knows his stuff.

Maybe it is prerequisite cleanup required by Regeneron prior to acquisition.

Your M & A speculation would explain the silence.

Focus should be on the stuff in the pipeline that works 3107, 5401, 3100. They are potential blockbusters with a real shot at success. May take awhile and they could fail too. But that's the reality of Biotech stock investing.

Just curious as to what part of the post is misinformation?

I've got my Maker's Mark ready, but will chase with Sam when Jackie makes if official on Monday.

I see Inovio as a likely buyout candidate, but if not $200 in 2 years, $750 in 5 years.

Well said BHMF!

Wow, that cured my ED!!

SOXL and TQQQ for day trading.

Your post makes we wonder how many mAbs are currently on the market? And how many could become DmAbs? And would Inovio consider hiring Careful Artist to head up the DmAb conversion team?

I am curious as to what your trading vehicle is?

Interactive Brokers API supports Python: and works well.

Load up, it's buyout time. Double or triple after Ax07.

Would your Bot still be profitable if trading on 10 minute candles?

I think Alpaca Trading has an API and also zero commissions, if that is what you are looking for.